| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-08-17 | 2009-06-30 | 13F-HR | Autoimmune Inc | AIMM.OB | US | Medical-Biomedical/Gene | 13,050 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Autoimmune Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Via Pharmaceuticals Inc | VIAP | US | Therapeutics | 102,881 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Via Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Sunesis Pharmaceuticals Inc | SNSS | US | Therapeutics | 0 | Sold All | -1,252,083 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Sunesis Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Symyx Technologies | SMMX | US | Chemicals-Specialty | 0 | Sold All | -73,127 | -100 % | - | - | - | -7.64 % | $34,370 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Symyx Technologies |
| 2009-08-17 | 2009-06-30 | 13F-HR | Pharmathene Inc | PIP | US | Medical-Biomedical/Gene | 838,175 | New Holding | 838,175 | 100 % | $2,338,508 | $3,327,555 | $989,047 | 42.29 % | $989,047 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmathene Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Anadys Pharmaceuticals Inc | ANDS | US | Therapeutics | 134,792 | Sold Some | -513,694 | -79.21 % | $301,934 | $281,715 | $-20,219 | -6.69 % | $77,054 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Siga Technologies Inc | SIGA | US | Medical-Drugs | 0 | Sold All | -573,832 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Siga Technologies Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Icagen Inc | ICGN | US | Medical-Drugs | 46,373 | No Change | 0 | 0 % | $31,997 | $22,259 | $-9,738 | -30.43 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Icagen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 504,234 | No Change | 0 | 0 % | $3,600,231 | $4,028,830 | $428,599 | 11.90 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunogen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 11,173,417 | No Change | 0 | 0 % | $68,604,780 | $81,007,273 | $12,402,493 | 18.07 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Incyte Corp Ltd |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inhibitex Inc | INHX | US | Medical-Biomedical/Gene | 620,904 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inhibitex Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Genomic Health Inc | GHDX | US | Medical-Biomedical/Gene | 5,383,081 | Added More | 182,694 | 3.51 % | $107,769,282 | $108,092,266 | $322,985 | 0.29 % | $10,962 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Genomic Health Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Metabasis Therapeutics Inc | MBRX | US | Medical-Biomedical/Gene | 2,018,903 | Sold Some | -227,856 | -10.14 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Metabasis Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 1,969,512 | Sold Some | -45,000 | -2.23 % | $14,082,011 | $12,033,718 | $-2,048,292 | -14.54 % | $46,800 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Amicus Therapeutics Inc | FOLD | US | Medical-Drugs | 1,121,337 | Sold Some | -180,667 | -13.87 % | $11,011,529 | $4,653,549 | $-6,357,981 | -57.73 % | $1,024,382 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amicus Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Critical Therapeutics Inc | CRTX | US | Therapeutics | 112,337 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Critical Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Curagen Corp | CRGN | US | Medical-Biomedical/Gene | 388,613 | No Change | 0 | 0 % | $536,286 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Curagen Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 636,215 | Sold Some | -1,447 | -0.22 % | $6,336,701 | $6,393,961 | $57,259 | 0.90 % | $-130 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cyclacel Pharmaceuticals Inc | CYCC | US | Therapeutics | 0 | Sold All | -85,811 | -100 % | - | - | - | -15.84 % | $13,730 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cyclacel Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 0 | Sold All | -1,298,432 | -100 % | - | - | - | 17.62 % | $-636,232 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cytokinetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Altus Pharmaceuticals Inc | ALTU | US | Therapeutics | 0 | Sold All | -70,494 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Altus Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ap Pharma Inc | APPA | US | Drug Delivery Systems | 2,884,546 | No Change | 0 | 0 % | $2,451,864 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ap Pharma Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ariad Pharmaceuticals Inc | ARIA | US | Medical-Biomedical/Gene | 0 | Sold All | -1,965,713 | -100 % | - | - | - | 3.82 % | $-157,257 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ariad Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Acadia Pharmaceuticals Inc | ACAD | US | Medical-Drugs | 3,359,373 | Added More | 423,953 | 14.44 % | $19,249,207 | $4,467,966 | $-14,781,241 | -76.78 % | $-1,865,393 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 1,217,235 | Added More | 13,152 | 1.09 % | $28,154,646 | $28,945,848 | $791,203 | 2.81 % | $8,549 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acorda Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Adolor Corp | ADLR | US | Medical-Drugs | 3,641,838 | Added More | 3,407,323 | 1452.92 % | $5,826,941 | $5,353,502 | $-473,439 | -8.12 % | $-442,952 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Adolor Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 4,134,718 | Added More | 23,590 | 0.57 % | $116,640,395 | $139,422,691 | $22,782,296 | 19.53 % | $129,981 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 0 | Sold All | -167,946 | -100 % | - | - | - | 9.12 % | $-231,765 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Allos Therapeutics Inc | ALTH | US | Therapeutics | 6,981,271 | Sold Some | -1,019,859 | -12.74 % | $49,985,900 | $43,353,693 | $-6,632,207 | -13.26 % | $968,866 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allos Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Insmed Inc | INSM | US | Therapeutics | 0 | Sold All | -13,699 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Insmed Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Neurogen Corp | NRGN | US | Therapeutics | 8,205,406 | No Change | 0 | 0 % | $1,641,081 | $1,394,919 | $-246,162 | -15.00 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Neurogen Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Threshold Pharmaceuticals Inc | THLD | US | Therapeutics | 1,504,711 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Threshold Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Torreypines Therapeutics Inc | TPTX | US | Medical-Biomedical/Gene | 33,546 | No Change | 0 | 0 % | $4,361 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Torreypines Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 3,053,817 | Sold Some | -670,768 | -18.00 % | $18,048,058 | $18,322,902 | $274,844 | 1.52 % | $-60,369 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Micromet Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 1,839,329 | No Change | 0 | 0 % | $25,934,539 | $24,941,301 | $-993,238 | -3.82 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Intermune Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Chelsea Therapeutics International Inc | CHTP | US | Medical-Drugs | 1,136,263 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Chelsea Therapeutics International Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Zymogenetics Inc | ZGEN | US | Medical-Drugs | 0 | Sold All | -582,500 | -100 % | - | - | - | 11.83 % | $-349,500 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Zymogenetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Depomed Inc | DEPO | US | Drug Delivery Systems | 183,145 | No Change | 0 | 0 % | $628,187 | $575,075 | $-53,112 | -8.45 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Depomed Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Novo Nordisk As | NVO | DK | Medical-Drugs | 0 | Sold All | -295,646 | -100 % | - | - | - | 6.65 % | $-1,185,540 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Novo Nordisk As |
| 2009-08-17 | 2009-06-30 | 13F-HR | Pharmasset Inc | VRUS | US | Medical-Drugs | 66,247 | No Change | 0 | 0 % | $1,071,876 | $1,397,812 | $325,935 | 30.40 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmasset Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Xenoport Inc | XNPT | US | Medical-Drugs | 203,695 | Sold Some | -340,576 | -62.57 % | $3,888,538 | $3,695,027 | $-193,510 | -4.97 % | $323,547 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Xenoport Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Biocryst Pharmaceuticals Inc | BCRX | US | Medical-Biomedical/Gene | 5,563,615 | Sold Some | -817,074 | -12.80 % | $52,909,979 | $62,757,577 | $9,847,599 | 18.61 % | $-1,446,221 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Senomyx Inc | SNMX | US | Research And Development | 34,114 | No Change | 0 | 0 % | $124,175 | $127,928 | $3,753 | 3.02 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Senomyx Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 331,480 | No Change | 0 | 0 % | $861,848 | $798,867 | $-62,981 | -7.30 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Supergen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Vanda Pharmaceuticals Inc | VNDA | US | Therapeutics | 0 | Sold All | -225,142 | -100 % | - | - | - | -21.02 % | $625,895 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Vanda Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Trimeris Inc | TRMS | US | Therapeutics | 3,461,175 | No Change | 0 | 0 % | $7,926,091 | $12,356,395 | $4,430,304 | 55.89 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Trimeris Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 4,801,442 | Added More | 987,046 | 25.87 % | $59,393,838 | $100,542,195 | $41,148,358 | 69.28 % | $8,458,984 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-17 | 2009-06-30 | 13F-HR | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 14,090,287 | Added More | 1,178,163 | 9.12 % | $158,093,020 | $133,153,212 | $-24,939,808 | -15.77 % | $-2,085,349 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Seattle Genetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ardea Biosciences Inc | RDEA | US | Medical-Drugs | 5,146,589 | No Change | 0 | 0 % | $101,799,530 | $70,096,542 | $-31,702,988 | -31.14 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ardea Biosciences Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 0 | Sold All | -36,578 | -100 % | - | - | - | -11.06 % | $121,073 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 187,926 | Sold Some | -236,325 | -55.70 % | $2,414,849 | $2,275,784 | $-139,065 | -5.75 % | $174,881 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Optimer Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Medarex Inc | MEDX | US | Therapeutics | 569,289 | Added More | 275,000 | 93.44 % | $9,074,467 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Medarex Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 571,579 | New Holding | 571,579 | 100 % | $12,649,043 | $16,352,875 | $3,703,832 | 29.28 % | $3,703,832 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Dendreon Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 47,704 | No Change | 0 | 0 % | $184,614 | $172,211 | $-12,403 | -6.71 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunomedics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Sucampo Pharmaceuticals Inc | SCMP | US | Medical-Drugs | 64,387 | No Change | 0 | 0 % | $443,626 | $266,562 | $-177,064 | -39.91 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Sucampo Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Targacept Inc | TRGT | US | Medical-Drugs | 425,073 | No Change | 0 | 0 % | $5,389,926 | $8,548,218 | $3,158,292 | 58.59 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Targacept Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inverness Medical Innovations Inc | IMA | US | Diagnostic Kits | 1,332,786 | Added More | 60,000 | 4.71 % | $46,487,576 | $53,164,834 | $6,677,258 | 14.36 % | $300,600 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inverness Medical Innovations Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Allergan Incunited States | AGN | US | Medical-Drugs | 25,800 | No Change | 0 | 0 % | $1,389,846 | $1,528,650 | $138,804 | 9.98 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allergan Incunited States |
| 2009-08-17 | 2009-06-30 | 13F-HR | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 2,334,327 | New Holding | 2,334,327 | 100 % | $30,299,564 | $28,175,327 | $-2,124,238 | -7.01 % | $-2,124,238 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 399,119 | Sold Some | -208,900 | -34.35 % | $20,790,109 | $21,173,263 | $383,154 | 1.84 % | $-200,544 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Celgene Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 102,705 | Added More | 20,539 | 24.99 % | $2,501,894 | $2,503,948 | $2,054 | 0.08 % | $411 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Myriad Genetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 1,808,190 | Sold Some | -1,591,571 | -46.81 % | $8,444,247 | $9,908,881 | $1,464,634 | 17.34 % | $-1,289,173 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inspire Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cepheid Inc | CPHD | US | Medical Instruments | 0 | Sold All | -60,100 | -100 % | - | - | - | 15.46 % | $-112,988 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cepheid Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Viropharma Inc | VPHM | US | Medical-Drugs | 9,405,977 | Added More | 2,371,631 | 33.71 % | $64,430,942 | $72,049,784 | $7,618,841 | 11.82 % | $1,921,021 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Viropharma Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Alsius Corp | ALUS | US | Medical Instruments | 62,872 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Alsius Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Infinity Pharmaceuticals Inc | INFI | US | Medical-Drugs | 391,974 | Added More | 306,342 | 357.74 % | $2,532,152 | $2,171,536 | $-360,616 | -14.24 % | $-281,835 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Infinity Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |